Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.77  0.01  0.36%   
About 54% of Lisata Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are impartial. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  

Lisata Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Lisata Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a month ago at prnewswire.com         
Regenity Biosciences Receives 510 Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus I...
prnewswire News
over a month ago at simplywall.st         
Shenzhen Chipscreen Biosciences Co., Ltd.s 50 percent Price Boost Is Out Of Tune With Revenues
Simply Wall St News at Macroaxis
over a month ago at zacks.com         
Heres What Could Help Castle Biosciences Maintain Its Recent Price Strength
zacks News
over a month ago at finance.yahoo.com         
Heres What Could Help Castle Biosciences Maintain Its Recent Price Strength
Yahoo News
over a month ago at finance.yahoo.com         
Investing in Kuros Biosciences a year ago would have delivered you a 786 percent gain
Yahoo News
over a month ago at simplywall.st         
LigaChem Biosciences Inc. Has Found A Path To Profitability
Simply Wall St News at Macroaxis
over a month ago at gurufocus.com         
Avidity Biosciences Stock Surges on FDA Decision
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Wedbush Comments on IGM Biosciences, Inc.s Q2 2025 Earnings
news
over a month ago at prnewswire.com         
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran
prnewswire News
over a month ago at globenewswire.com         
REPEAT Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New F...
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events
Yahoo News
over a month ago at finance.yahoo.com         
Neurocrine Biosciences, Inc. Stocks Been Sliding But Fundamentals Look Decent Will The Market Correc...
Yahoo News
over a month ago at businesswire.com         
Integrated Biosciences Raises 17 Million to Accelerate Development of Drugs Targeting Age-Related Di...
businesswire News
over a month ago at thelincolnianonline.com         
Calithera Biosciences Research Coverage Started at StockNews.com
news
over two months ago at finance.yahoo.com         
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreem...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Harmony Biosciences Holdings, Inc. Just Recorded A 19 percent EPS Beat Heres What Analysts Are Forecasting Next
10/31/2024
2
IGM Biosciences, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/08/2024
3
Inhibrx Biosciences GAAP EPS of -2.84
11/15/2024
4
Taconic Biosciences Announces New U.S. West Coast Production Location
11/20/2024
5
Parse Biosciences Partners with OMAPiX to Expand Access to Single Cell Sequencing
11/21/2024
6
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
11/22/2024
7
Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, ...
11/25/2024
8
Neurogene and Ventyx Biosciences rises after insider buying by executives
11/26/2024
9
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635
11/29/2024

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account